Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim+18 more
wiley +1 more source
The Environmental Distribution of Staphylococcus Aureus in an Operating Suite
Robert I. Wise+3 more
openalex +2 more sources
Objectives This study aims to describe the frequency and timing of physician referrals to physical therapists (PT) and other treatments prescribed over 12 months in patients with recent onset of knee osteoarthritis (KOA). The study also aims to identify determinants of early PT referrals.
Samannaaz S. Khoja+4 more
wiley +1 more source
Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082]. [PDF]
Cline EN+16 more
europepmc +1 more source
Mémoire sur les centres de moyennes harmoniques; pour faire suite au traité des propriétés projectives des figures, et servir d'introduction à la Théorie générale des propriétés projectives des courbes et surfaces géométriques. [PDF]
Jocelyn Poncelet
openalex +1 more source
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health. Methods We conducted a search for keywords which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the list of
Joy Buie+11 more
wiley +1 more source
Blurry With a Chance of Ultrasound: A Case of Sudden Vision Loss. [PDF]
Cipi A, Sealy E.
europepmc +1 more source
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. While pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen+4 more
wiley +1 more source
Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa. [PDF]
Marinkovich MP+11 more
europepmc +1 more source